Literature DB >> 14102080

CLINICAL EFFECTS OF PROLONGED (CONTINUOUS) INFUSION OF STREPTONIGRIN (NSC-45383) IN ADVANCED CANCER.

R D SULLIVAN, E MILLER, W Z ZUREK, F R RODRIGUEZ.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS; ANTINEOPLASTIC AGENTS; BONE MARROW; INFUSIONS, PARENTERAL; NEOPLASM THERAPY; PYRIMIDINES; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1963        PMID： 14102080

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  3 in total

1.  Analysis of the activities of RAD54, a SWI2/SNF2 protein, using a specific small-molecule inhibitor.

Authors:  Julianna S Deakyne; Fei Huang; Joseph Negri; Nicola Tolliday; Simon Cocklin; Alexander V Mazin
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

2.  Biological assay of streptonigrin (NSC 45383) in body fluids and tissues of mice.

Authors:  R F Pittillo; C Woolley
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

3.  Streptonigrin Inhibits SENP1 and Reduces the Protein Level of Hypoxia-Inducible Factor 1α (HIF1α) in Cells.

Authors:  Nigus Ambaye; Chih-Hong Chen; Swati Khanna; Yi-Jia Li; Yuan Chen
Journal:  Biochemistry       Date:  2018-03-01       Impact factor: 3.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.